Insights
Access our latest insights & resources
Biopharma: The CAR-T Party is Getting Crowded
Fundamental, Research
Biopharma companies building out portfolios of candidates targeting blood cancers...
Read moreCoinbase in a Lose-Lose as SEC Labels More Digital Assets Securities
Policy & Legal, Research
SEC civil suit against former COIN employee puts company in bind...
Read moreSingle Stock ETFs Launch in the U.S. – Providing Opportunities and Risks
ETF & Mutual Fund, Research
Launch of eight single stock ETFs likely precursor to more coming...
Read moreThe SEC Seeks Comments on Regulation of Index Providers
ETF & Mutual Fund, Research
SEC seeks public comment related to advisory exemption for index providers...
Read moreCredit Card Routing Competition Legislation Faces Low Odds [V, MA]
Policy & Legal, Research
Odds extremely low Congress passes new regulations on card transactions...
Read moreThe SEC’s Proposed Changes to the ‘Names Rule’ to Impact Thematic and Factor Fund
ETF & Mutual Fund, Research
SEC proposes changes aimed at naming and disclosure requirements...
Read moreTwitter, Inc. (TWTR) Finding a Way Out Will Be Harder Than a Tweet
Policy & Legal, Research
Elon Musk’s proposed take-private buyout of Twitter
Read moreOil & Gas: Where Do We Go From Here
Fundamental, Video
What investors can expect to see in 2022...
Read moreMetaverse ETFs: A Rapidly Growing Universe
ETF & Mutual Fund, Research
Metaverse themed ETFs gaining steam; could exceed $1 trillion by end of decade...
Read more